These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [Effects of guanfacine on pre- and postsynaptic alpha-adrenoceptors studied in comparison with those of clonidine].
    Author: Nakagawa Y, Chin W, Imai S.
    Journal: Nihon Yakurigaku Zasshi; 1982 May; 79(5):431-9. PubMed ID: 6127290.
    Abstract:
    Intravenous injections of guanfacine (1 microgram-3 mg/kg) elevated dose-dependently blood pressure in adrenalectomized, pitched rats. The vasopressor activity of guanfacine was weaker than those of clonidine, an alpha 2-agonist and 1-phenylephrine, an alpha 1-agonist. However, the maximal response produced by guanfacine was the same as that produced by clonidine, while it was much smaller than that produced by 1-phenylephrine. The dose-response curve to guanfacine for increase in blood pressure was shifted in a parallel fashion to the right by 1 mg/kg of yohimbine, an alpha 2-antagonist and by 1 mg/kg of phentolamine, a nonselective alpha 1- and alpha 2-antagonist. However, 0.1 mg/kg of prazosin, a selective alpha 1-antagonist, produced an inhibition of the blood pressure rise induced by higher doses of guanfacine, but not that induced by lower doses. Guanfacine (1 microgram-1 mg/kg) inhibited dose-dependently the tachycardia induced by electrical stimulation of spinal nerves at C7-Th1 in adrenalectomized, pithed rats. The maximal inhibition by guanfacine of heart rate increase induced by electrical stimulation was about 60%. These inhibitory effects were antagonized by yohimbine and phentolamine, but not by prazosin. These results indicate that guanfacine is an alpha 2-agonist with approximately equal potency towards the pre- and postsynaptic alpha 2-adrenoceptors, just as clonidine is, but is weaker as an alpha 2-agonist than clonidine.
    [Abstract] [Full Text] [Related] [New Search]